Menu Search
Equities

Quanterix Corp

QTRX:NMQ

Quanterix Corp

Actions
Health CareMedical Equipment and Services
  • Price (USD)11.72
  • Today's Change0.70 / 6.35%
  • Shares traded417.58k
  • 1 Year change-50.32%
  • Beta1.3041
Data delayed at least 15 minutes, as of Nov 21 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Quanterix Corp grew revenues 15.96% from 105.52m to 122.37m while net income improved from a loss of 96.70m to a smaller loss of 32.33m.
Gross margin57.42%
Net profit margin-30.71%
Operating margin-44.69%
Return on assets-9.45%
Return on equity-11.48%
Return on investment-10.30%
More ▼

Cash flow in USDView more

In 2023, cash reserves at Quanterix Corp fell by 164.31m. Cash Flow from Financing totalled 2.69m or 2.20% of revenues. In addition the company used 18.90m for operations while cash used for investing totalled 148.40m.
Cash flow per share-0.8702
Price/Cash flow per share--
Book value per share8.77
Tangible book value per share8.64
More ▼

Balance sheet in USDView more

Quanterix Corp appears to have little financial risk as the company holds a substantial amount of cash on its books with little or no debt.
Current ratio9.74
Quick ratio8.99
Total debt/total equity0.00
Total debt/total capital0.00
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.